ArticleHuman genomics2026
Genetic variants identification through whole-genome sequencing based on dried blood spots in 92 Chinese children with Autism.
Article in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorder with high heterogeneity. We hence to investigate the genetic etiology of ASD and the potential of whole-genome sequencing (WGS) from dried blood spots for the presymptomatic risk assessment. Total 92 individuals diagnosed with ASD were recruited to identify the genetic etiologies of ASD using WGS of newborn dried blood spots. Variants were verified with a minigene splicing assay and the construction of three-dimensional protein models. Overall, a positive molecular diagnosis was obtained for 10 cases, a rate of 10.87%. Among the 10 cases, five cases (50.0%, 5/10) were identified with likely pathogenic exon-level CNVs, two cases (20.0%, 2/10) were identified with pathogenic large CNVs, one case (10%, 1/10) was identified with the chromosomal translocation t(8;9)(q13.3;q21.13), and 2 cases (20.0%, 2/10) were identified with likely pathogenic SNVs/Indels. Total 245 variants of 173 genes were classified as "VUS". Further functional analysis showed that one splicing variant were predicted to generate a truncated protein. Our study demonstrated the utility of WGS derived from dried blood spots for identifying ASD-associated risk genes and variants. The introduction of ASD to the newborn genetic screening should be considered, which may facilitate presymptomatic risk identification and enable earlier, more personalized interventions for high-risk infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.